| Name | Title | Contact Details |
|---|
Bacterin is an accredited tissue bank and medical device company that designs, processes, manufactures, and markets advanced medical products. Using designs focused on efficacy and safety for the patient, and functionality and ease of use for the surgeon, our innovative products fulfill niche needs in the industry. It is important that you know and trust your allograft provider. We are a specialty tissue bank focused on processing and distributing quality, cost-effective allografts to you and your patients.
Located in northern California, Consensus Orthopedics is committed to providing proven and reliable total joint implants and instruments to the global market. Consensus headquarters include administrative offices, research and design workrooms, manufacturing, inspection, clean room and warehouse space. With over 25 years of orthopedic design and manufacturing experience, together, through a focus on patient care and clinician relationships, Consensus is dedicated to creating one team, focused on restoring mobility and renewing lives.
Mizuho OSI is a Union City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Biowatch Medical Inc (Main) is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bioject Medical Technologies Inc. is a leader in the development of needle-free injection therapies with over 25 years of experience improving the administration of liquid medications; pharmaceuticals, vaccines, and biologics. Bioject's technology works by forcing liquid medication at high speed through a tiny orifice held against the skin. This creates an ultra-fine stream of fluid that penetrates the skin, delivering medication in a fraction of a second. Bioject's systems are designed to deliver injected medications comfortably, accurately, and quickly - without the use of a needle. Bioject was founded in 1985 to develop needle-free injection systems to improve the comfort and safety of routine injections. From its early work focused on improving the characteristics of these delivery systems, the Company has created a broad technology platform for delivering a wide range of medications and vaccines to the subcutaneous, intramuscular and intradermal depths. Bioject has developed a portfolio of injection systems based on its core technology, the foundation for which is more than 80 issued and pending patents and an extensive body of technical know-how. These include durable devices designed for heavy use in a professional healthcare environment, and small, lightweight injectors designed for home use. With partners, Bioject is also developing inexpensive, pre-filled, disposable injection systems. Further validating its technology, Bioject and its partners have the largest volume of published studies using needle-free injection technology systems. Bioject's strategy is to form strategic partnerships with pharmaceutical, biotechnology, and animal health companies. The result is mutually beneficial agreements with these partners to develop customized injection systems to enhance the delivery of their injected medication or vaccine. Bioject has alliances with leading pharmaceutical, biotechnology, and animal health companies. Bioject's products are also used in public health, Physicians offices, and in cutting edge biomedical research at leading institutions around the globe.